Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

Shiraz E-Medical Journal

Home
Current IssueAll IssuesIn PressAccepted ManuscriptsSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review

- Kumar V. , et al.

2. Imatinib efficacy, safety and resistance in iranian patients with chronic myeloid leukemia: A review of literature

- Amouei A. , et al.

3. Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis

- Dai J. , et al.

4. Imatinib induced melasma-like pigmentation: Report of five cases and review of literature

- Ghunawat S. , et al.

5. Non-hematological adverse events of imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP)

- Payandeh M. , et al.

6. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor

- Hamza I. , et al.